Department of Gastroenterology, Shanghai East Hospital Affiliated to Tongji University, Shanghai (200120), China.
Chin J Integr Med. 2012 Jun;18(6):445-50. doi: 10.1007/s11655-012-1115-x. Epub 2012 Jul 22.
To investigate the effects of oxymatrine on hepatic gene expression profile in a rat model of liver fibrosis.
Forty healthy male SD rats were randomly divided into three groups, a normal group (n=8), a model group (n=16), and an oxymatrine treatment group (n=16). Experimental hepatic fibrosis was induced by subcutaneous injection of carbon tetrachloride (CCl(4)). The rats in the treatment group received oxymatrine via celiac injection at a dosage of 40 mg/kg once a day at the same time. The rats in the model and normal groups received saline at the same dosage via celiac injection. Serum levels of aspartate aminotransferase (AST), alanine transaminase (ALT), alkaline phosphatase (AKP), hyaluronic acid (HA), and laminin (LN) were assayed. The deposition of collagen was observed with HE and Masson staining. Effect of oxymatrine on hepatic gene expression profile was detected by oligonucleotide microarray analysis with Affymetrix gene chip rat U230A. Quantitative real-time polymerase chain reaction (QRT-PCR) was carried out to confirm the expression changes of six genes.
Oxymatrine significantly improved liver function, lowered serum levels of HA and LN, and decreased the degree of liver fibrosis, compared with the model group (P<0.05). A total of 754 differentially expressed genes were identified by gene chip between the model group and the normal group, among which 438 genes increased and 316 genes decreased over two folds. Compared with the model group, 86 genes were downregulated markedly in the oxymatrine group (P<0.05), including collagen I and other genes related to extracellular material (ECM), integrin signal transduction genes, early growth response factor genes, and proinflammatory genes; 28 genes were upregulated significantly (P<0.05), including cytochrome P450 (CYP450) superfamily genes, glycolipids metabolism and biological transformation related genes. Six genes were confirmed with QRT-PCR, consistent with the result from microarray.
Oxymatrine could affect the expression of many functional genes and may be useful in the prevention and treatment of liver fibrosis.
研究氧化苦参碱对肝纤维化大鼠模型肝组织基因表达谱的影响。
40 只健康雄性 SD 大鼠随机分为三组,正常组(n=8)、模型组(n=16)和氧化苦参碱治疗组(n=16)。采用皮下注射四氯化碳(CCl4)诱导实验性肝纤维化。治疗组大鼠同时经腹腔注射氧化苦参碱,剂量为 40mg/kg,每日 1 次。模型组和正常组大鼠同时经腹腔注射等容量生理盐水。检测血清天门冬氨酸氨基转移酶(AST)、丙氨酸氨基转移酶(ALT)、碱性磷酸酶(AKP)、透明质酸(HA)和层粘连蛋白(LN)水平。采用 HE 和 Masson 染色观察胶原沉积。采用 Affymetrix 基因芯片大鼠 U230A 寡核苷酸微阵列分析检测氧化苦参碱对肝组织基因表达谱的影响。采用实时定量聚合酶链反应(QRT-PCR)验证 6 个基因的表达变化。
与模型组相比,氧化苦参碱能显著改善肝功能,降低血清 HA 和 LN 水平,减轻肝纤维化程度(P<0.05)。基因芯片比较模型组和正常组,共发现 754 个差异表达基因,其中 438 个基因上调,316 个基因下调 2 倍以上。与模型组相比,氧化苦参碱组 86 个基因明显下调(P<0.05),包括胶原 I 等细胞外基质(ECM)相关基因、整合素信号转导基因、早期生长反应因子基因和促炎基因;28 个基因明显上调(P<0.05),包括细胞色素 P450(CYP450)超家族基因、糖脂代谢和生物转化相关基因。6 个基因通过 QRT-PCR 验证,与芯片结果一致。
氧化苦参碱可影响多个功能基因的表达,可能有助于预防和治疗肝纤维化。